Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Platelet-activating factor receptor (PAFR) is a member of the G protein-coupled receptor (GPCR) superfamily, specifically the rhodopsin-like family, encoded by the PTAFR gene (UniProt: P25105). It is primarily activated by platelet-activating factor (PAF), a potent phospholipid mediator involved in a wide array of physiological and pathological processes, including platelet aggregation and inflammatory cell activation. Upon activation, PAFR triggers intracellular signaling pathways such as the activation of phospholipase C and the mobilization of calcium, which are critical for the immune response and vascular permeability (StatPearls: NBK557544). PAFR plays a significant role in the pathogenesis of asthma, anaphylaxis, and systemic inflammatory response syndrome, making it a key target for anti-inflammatory drug development. While several antagonists like lexipafant and rupatadine have been developed, clinical success has been varied, with some drugs showing efficacy in allergic rhinitis while others failed in acute systemic conditions like pancreatitis (DrugBank: DB04854). The receptor is also implicated in cancer progression, where it may promote tumor cell metastasis and angiogenesis.
Competitive antagonism of the platelet-activating factor receptor, preventing the binding of the phospholipid mediator PAF and subsequent downstream signaling.
6 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet-activating factor receptor (PTAFR) (PTAFR).